Healthcare / 醫療
-
Research ENThe Language of the Cell: Biohub's $1.8 Billion Virtual Biology Bet Pulls In Google, Meta, and Washington
Meta, Google DeepMind, Isomorphic Labs, the DOE, and NIH pool $1.8 billion into Biohub's Virtual Biology Initiative to build the open datasets needed to train AI models that predict how living cells behave.
-
Research 中細胞的語言：Biohub 18 億美元「虛擬生物學」計畫，把 Google、Meta 與美國政府拉進同一張桌
Meta、Google DeepMind、Isomorphic Labs、美國能源部與 NIH 共同投入 18 億美元，擴大 Biohub 的虛擬生物學倡議，打造訓練細胞預測 AI 模型所需的開放資料集。
-
Industry ENEightfold Faster Antibodies: Danaher's First AI Autonomous Lab Wires a Design-Make-Test-Learn Loop
Danaher will run its first AI-powered autonomous lab at Abcam from early 2027, combining robotics, orchestration tech and a closed feedback loop targeting 8x faster reagent discovery and ten times more reagents per year.
-
Industry 中抗體開發快八倍：Danaher 首座 AI 自主實驗室把「設計—製造—測試—學習」迴圈全自動化
Danaher 宣布將於 2027 年初在 Abcam 啟用首座 AI 自主實驗室，整合機器人、設備編排技術與閉環回饋系統，目標將親和試劑發現速度提升 8 倍、年產量提高 10 倍。
-
Research ENWatermarks That Survive the Wet Lab: DeepMind's SynthID Bio Signs AI-Designed Proteins
Google DeepMind extends SynthID watermarking to synthetic biology: SynthID Bio embeds a verifiable signature into AI-generated protein sequences and predicted 3D structures — and proves it survives synthesis and wet-lab testing without hurting function.
-
Research 中能在濕實驗室存活的浮水印：DeepMind 的 SynthID Bio 為 AI 蛋白質設計簽名
Google DeepMind 把 SynthID 浮水印技術延伸到合成生物學：SynthID Bio 將可驗證的簽名嵌入 AI 生成的蛋白質序列與預測 3D 結構，並證明簽名在 DNA 合成與濕實驗室測試後依然存在、不損害蛋白功能。
-
Policy EN22 Academies, One Verdict: EASAC and FEAM Publish the Blueprint for Safe AI in European Healthcare
Europe's science and medicine academies launch a joint report in Brussels on how to validate, regulate, and deploy AI in healthcare — spanning the AI Act, MDR, EHDS, and liability.
-
Policy 中22 個科學院、一份結論：EASAC 與 FEAM 發布歐洲醫療 AI 安全落地藍圖
歐洲各國科學院與醫學院聯合在布魯塞爾發表報告，為醫療 AI 的驗證、監管與部署提出完整路線圖，涵蓋 AI Act、醫療器材法規、歐洲健康資料空間與產品責任指令。
-
Industry ENFrom $2.2B to $4B in 13 Months: EliseAI Closes $350M as AI's Quiet Utility Play
EliseAI raised $350M at a $4B valuation led by a16z and Bessemer to push agentic AI deeper into housing and healthcare — the two largest household expenses in America.
-
Industry 中13 個月估值翻倍：EliseAI 完成 3.5 億美元融資，押注 AI 的「基礎設施路線」
EliseAI 以 40 億美元估值完成 3.5 億美元融資，由 a16z 與 Bessemer 領投，將自主代理 AI 推向住房與醫療兩大美国家庭支出產業。
-
Industry ENDesigning Drugs for Pathogens That Don't Exist Yet: Inside Red Queen Bio, OpenAI's Biodefense Bet
A WSJ profile puts the spotlight on Red Queen Bio, the OpenAI-backed startup with $36M raised that designs antibody countermeasures against AI-enabled biological threats — before future AI systems create them.
-
Industry 中為尚未存在的病原體設計藥物：OpenAI 生物防禦布局 Red Queen Bio 深度解析
《華爾街日報》專文聚焦 Red Queen Bio：這家獲 OpenAI 領投、累計募資 3,600 萬美元的新創，正搶在未來 AI 系統設計出生物武器之前，先用 AI 設計好抗體解藥。
-
Industry ENEvolution as Training Data: Basecamp Research's $140M Series C Bets on Programmable Biology
London's Basecamp Research raised a $140M Series C led by S32 with NVIDIA and Anthropic's Anthology Fund on the cap table, valuing it at $800M. Its EDEN models, trained on 15 trillion DNA tokens from 30+ countries, have already designed an antibiotic that matched a last-resort drug in mice.
-
Industry 中把演化變成訓練資料：Basecamp Research 募得 1.4 億美元，押注可程式化的生物學
倫敦的 Basecamp Research 完成 8 億美元估值、1.4 億美元的 C 輪融資，S32 領投，NVIDIA 與 Anthropic 的 Anthology Fund 均參與。其 EDEN 生物基礎模型以來自 30 多國、15 兆 DNA token 的資料訓練，設計出的抗生素已在小鼠實驗中比擬最後一線藥物。
-
Industry ENA Discovery Nobody Can Explain Wipes Billions Off Gene-Editing Stocks
Anthropic says 950 Claude agents found a CRISPR-like enzyme system in phage DNA — and even though nobody knows what it does, CRSP, BEAM, PRME and NTLA sold off hard. When AI hypotheses start moving biotech valuations, the market is telling you what it thinks the moat is made of.
-
Industry 中一個沒人能解釋的發現，蒸發基因編輯股數十億美元市值
Anthropic 表示約 950 個 Claude 代理在噬菌體 DNA 中找到類 CRISPR 酶系統——即使沒有人知道它有什麼功能，CRSP、BEAM、PRME 與 NTLA 仍應聲重挫。當 AI 的假設開始撼動生技估值，市場等於親口告訴你：它認為這些公司的護城河是什麼做的。
-
Industry ENA $15 Billion Diagnosis: OpenEvidence's Quiet New Round Puts It on the M&A Exam Table
The 'ChatGPT for doctors' closed a $250M round at a $15B valuation — its second doubling in nine months — while its founders field acquisition interest instead of rushing to an IPO.
-
Industry 中150 億美元的診斷書：OpenEvidence 低調完成新一輪募資，整家公司被放上併購手術台
這家「醫師版 ChatGPT」以 150 億美元估值悄悄完成 2.5 億美元募資——九個月內第二次估值翻倍——同時創辦人正在評估出售公司的可能性，而非急著走向 IPO。
-
Industry ENNearly a Billion Dollars for Care That Never Happened: Blue Cross Pins $942M on AI Coding Tools
A Blue Cross Blue Shield Association study finds AI coding tools and ambient scribes drove $942 million in added insurer costs in 2024–2025, as diagnosis codes surged without matching treatments — the clearest quantification yet of AI-driven upcoding.
-
Industry 中近十億美元的「未曾發生的醫療」：藍十字藍盾協會將 9.42 億美元額外成本歸咎於 AI 編碼工具
藍十字藍盾協會（BCBSA）研究顯示，AI 編碼工具與環境式抄寫員在 2024–2025 年為保險公司增加 9.42 億美元支出，診斷代碼暴增但治療並未隨之增加——這是迄今為止對 AI 驅動向上編碼（upcoding）最明確的量化。
-
Research ENOne Model, Three Countries, a Million Patients: Google's ARDA Retinal AI Publishes Its Scaling Lessons
A Nature Medicine Comment from Google and clinical partners in India, Thailand and Australia distils what a decade of deploying diabetic-retinopathy AI taught about scaling clinical models beyond the pilot stage.
-
Research 中一個模型、三個國家、百萬病患：Google ARDA 視網膜 AI 發表規模化部署經驗
Google 與印度、泰國、澳洲臨床夥伴在《Nature Medicine》發表評論，整理糖尿病視網膜病變 AI 十年部署、突破百萬人次篩檢的規模化心得。
-
Research EN1,215 Conversations, 80 Clinicians: OpenAI Open-Sources MentalHealthBench
OpenAI's new open benchmark scores frontier models on the full spectrum of mental health conversations — from everyday stress to psychiatric emergencies — using rubrics written by 80+ licensed clinicians across 20+ countries.
-
Research 中1,215 場對話、80 位臨床專家：OpenAI 開源 MentalHealthBench 心理健康評測基準
OpenAI 推出全新開放基準，以 1,215 場擬真心理健康對話評測前沿模型——從日常壓力到精神急症全面覆蓋，評分標準由 20 多國、80 餘位執業臨床心理師與精神科醫師共同撰寫。
-
Industry EN128 GOPS in Your Earbuds: Qualcomm's Snapdragon Sound Elite Gen 2 Makes Hearables the New AI Frontier
Qualcomm's new hearables platform doubles on-device AI performance, adds micro-power Wi-Fi 6E for direct-to-cloud agents, and launches a health alliance with Optum and Scripps — turning earbuds into the quiet vanguard of personal AI.
-
Industry 中128 GOPS 塞進耳機裡：Qualcomm Snapdragon Sound Elite Gen 2 讓穿戴裝置成為個人 AI 新戰場
Qualcomm 全新聽穿戴平台將裝置端 AI 效能翻倍、內建微功耗 Wi-Fi 6E 直連雲端代理，並與 Optum、Scripps 組成健康聯盟——耳機正悄悄成為個人 AI 的先鋒載體。
-
Research EN146 Conditions, One Pass, Open Weights: Alibaba's DAMO RADAR Reads Abdominal CT Better Than 23 of 26 Radiologists
Published in Science and open-sourced under CC BY-NC-SA, Alibaba DAMO's RADAR vision-language model was trained on 424,911 CT exams without manual annotation, hit a mean AUC of 0.913 across 146 abdominal findings, and runs on a single 16GB GPU.
-
Research 中一次掃描、146 種病症、開放權重：阿里 DAMO RADAR 讀腹部 CT 贏過 26 位放射科醫師中的 23 位
登上《Science》並以 CC BY-NC-SA 開源的阿里 DAMO RADAR 視覺語言模型，以 424,911 次 CT 檢查訓練、無需人工標註，在 146 項腹部病徵上達到平均 AUC 0.913，單張 16GB 顯卡即可推理。
-
Industry ENEvery Enterprise Is a Content Enterprise: Brahma AI Raises $150M at a $2B Valuation
Backed by Hollywood VFX heritage and an Emmy, Brahma AI raised $150M led by Multiples at a $2B valuation to build the AI-native operating system for enterprise audiovisual content.
-
Industry 中每家企業都將成為內容企業：Brahma AI 以 20 億美元估值募得 1.5 億美元
繼承好萊塢 VFX 血統與艾美獎肯定，Brahma AI 獲 Multiples 領投 1.5 億美元、估值約 20 億美元，要打造企業影音內容的 AI 原生作業系統。
-
Industry ENA Doctor in Every Phone: Anthropic and OpenEvidence Bring Free Clinical AI to 100 Countries
Anthropic is supplying back-end AI capacity so OpenEvidence can offer its clinical decision-support platform free to physicians in roughly 100 low- and middle-income countries — a deployment that treats frontier-model access as infrastructure for global health equity.
-
Industry 中讓每支行動電話都有一位醫師顧問：Anthropic 攜手 OpenEvidence 將免費臨床 AI 帶進 100 國
Anthropic 將提供後端模型運算能量，讓 OpenEvidence 的臨床決策支援平台免費開放給約 100 個中低所得國家的醫師使用——把前沿模型的存取權，當作全球健康公平的基礎建設來經營。
-
Research EN1% of Tokens Can Be Enough: The Signal-to-Noise Trick That Makes Sparse Distillation Actually Work
MBZUAI and Ant Group researchers show that scoring just 0.1%–1% of tokens during on-policy distillation can match full supervision — if you select tokens by gradient reliability, not just usefulness.
-
Research 中1% 的 Token 就可能夠了：讓稀疏蒸餾真正奏效的訊號雜訊比技巧
MBZUAI 與螞蟻集團的研究人員證明，在線策略蒸餾中只對 0.1%–1% 的 token 進行監督就能追平全量監督——前提是依「梯度可靠度」而非僅依「有用性」來挑選 token。
-
Industry ENThe $25M Seed That Wants to Give Every Small Business a Benefits Department: Inside Corridor's AI-Native Brokerage
Corridor launches with $25M from Bain Capital Ventures, pairing licensed advisors with AI agents that quote every plan on the market — targeting the 6 million US businesses traditional brokers won't serve.
-
Industry 中2500 萬美元種子輪，要讓每家小企業都擁有福利部門：揭開 Corridor 的 AI 原生保險經紀模式
Corridor 以 Bain Capital Ventures 領投的 2,500 萬美元種子輪亮相，結合持牌顧問與 AI代理人，為傳統經紀不願服務的 600 萬家美國小企業報價全市場保單。
-
Meta ENMedical AI Has a Proof Problem: Clinicians Push Back on Deployment Beyond Diagnostics
The FT's Big Read argues medical AI is being deployed at enormous scale on remarkably thin evidence that it improves patient outcomes — and the clinicians being asked to trust it are pushing back.
-
Meta 中醫療 AI 的「證據問題」：臨床醫師集體反彈，拒絕再為薄弱實證背書
《金融時報》深度報導指出，醫療 AI 正以空前規模部署，但證明它能改善病人預後的證據卻薄得驚人——第一線臨床醫師開始集體說不。
-
Research ENOne Model, 146 Diseases: Alibaba's DAMO RADAR Reads Abdominal CT Better Than 23 of 26 Radiologists
Alibaba DAMO Academy and Zhejiang University's open-source RADAR, published in Science, identifies 146 conditions across 18 abdominal organs from contrast CT scans — AUC 0.913 on ~39,000 internal exams and 0.895 across 8 external hospitals — beating 23 of 26 radiologists in a head-to-head reader study.
-
Research 中一個模型看穿 146 種疾病：阿里巴巴達摩院 RADAR 讀腹部 CT，勝過 26 位放射科醫師中的 23 位
阿里巴巴達摩院與浙江大學醫學院附屬第一醫院發表於《Science》的開源模型 RADAR，能從顯影劑 CT 一次辨識 18 個腹部器官、146 種疾病——近 3.9 萬例內部驗證 AUC 達 0.913、8 家外部醫院 0.895，並在人機對決中擊敗 26 位放射科醫師中的 23 位。
-
Research ENOne Model, 146 Diseases: Alibaba's DAMO RADAR Reads Abdominal CT Scans Better Than 23 of 26 Radiologists — and It's Fully Open-Sourced
Published in Science on September 17, DAMO RADAR is a vision-language model trained on 400,000+ CT exams that matches expert radiologists across 146 abdominal findings — and Alibaba has released the weights, code, and training framework for anyone to build on.
-
Industry ENClaude Gets a Wet Lab: Anthropic Quietly Opens a Physical Biology Lab in the Bay Area
Reuters confirms Anthropic has set up a wet lab for physical biology experiments in the San Francisco Bay Area, testing whether Claude can direct robotic systems while drawing hard lines around drug discovery and clinical trials.
-
Industry 中Claude 有了自己的實體實驗室：Anthropic 低調在灣區設立濕實驗室
路透社證實 Anthropic 已在舊金山灣區設立濕實驗室，進行實體生物學實驗，測試 Claude 能否指揮機器人系統執行實驗，同時對藥物開發與臨床試驗劃出明確界線。
-
Industry ENOzempic Maker Meets Claude: Novo Nordisk Partners with Anthropic to Compress Drug Discovery Timelines
Novo Nordisk will deploy Anthropic's Claude Science workbench and frontier models across R&D and AI-driven software development, in the Danish pharma giant's third major AI alliance of the year — a bid to compress 'a century's worth' of medical breakthroughs into a decade.
-
Industry 中Ozempic 大藥廠遇上 Claude：諾和諾德攜手 Anthropic，要讓藥物研發時程大幅壓縮
諾和諾德（Novo Nordisk）將在研發部門與全公司軟體開發導入 Anthropic 的 Claude Science 工作平台與前沿模型，這是這家丹麥製藥巨頭今年第三個重大 AI 聯盟——目標是把「一世紀的醫學突破」壓縮進十年之內。
-
Research ENA Mouse Cortex Made of Human Cells: Stanford's Xenocortical Mice Redefine Brain Research
Stanford scientists bioengineered mice missing most of their cerebral cortex, then transplanted human cortical organoids that grew to fill over 90% of the empty cortex volume, connected to the spinal cord, and even produced rare von Economo neurons never before seen in a lab.
-
Research 中人類細胞打造的小鼠大腦皮質：斯坦福「異皮質小鼠」重新定義腦科學研究
斯坦福醫學院以基因工程培育出幾乎缺少整個大腦皮質的小鼠，再植入人類皮質類器官；三個月後人類組織占據皮質體積超過 90%，連結至脊髓，甚至長出從未在實驗室出現過的罕見馮·艾柯諾莫神經元。
-
Industry ENA Century of Breakthroughs in a Decade: Novo Puts Claude Science at the Heart of Its Drug Discovery Pipeline
Fresh off its rebrand, Novo (formerly Novo Nordisk) is deploying Anthropic's Claude Science workbench and frontier models across R&D — aiming to become 'the world's most AI-driven healthcare company.'
-
Industry 中十年壓縮一世紀：Novo 攜手 Anthropic，把 Claude Science 推上藥物開發核心
品牌更名為 Novo 兩天後，這家丹麥藥廠正式宣布與 Anthropic 合作，將 Claude Science 工作台與前沿模型導入藥物探索與開發流程，目標成為「全球最 AI 驅動的醫療保健公司」。
-
Industry ENTikTok's Parent Exits the Lab: ByteDance Spins Off Anew Labs, Which Raises $290M at a $1.5B Valuation for AI Drug Discovery
ByteDance's AI drug discovery unit Anew Labs has completed its spin-off with a $290M round led by HSG and IDG Capital at a $1.5B valuation, taking its AI-designed oral IL-17 inhibitor and a roughly 50-person team independent.
-
Industry ENTikTok 母公司送實驗室出嫁：ByteDance 分拆 Anew Labs，以 15 億美元估值融資 2.9 億美元投入 AI 藥物研發
ByteDance 的 AI 藥物研發部門 Anew Labs 完成分拆，由 HSG 與 IDG Capital 領投 2.9 億美元、估值 15 億美元，帶著 AI 設計的口服 IL-17 抑制劑與約 50 人核心團隊獨立營運。
-
Industry ENData as the New Drug: OpenAI Foundation Commits $125M+ to Public Data for Health, With $40M to UNC for Cancer Vaccines
The OpenAI Foundation's second science program funds open biological datasets — a $40M grant to UNC Lineberger will directly measure tumor antigens and T-cell responses to make personalized cancer vaccines less of a guessing game.
-
Industry 中資料即新藥：OpenAI 基金會豪擲逾 1.25 億美元啟動 Public Data for Health，4,000 萬美元投向 UNC 癌症疫苗計畫
OpenAI 基金會第二個科學計畫聚焦開放生物資料集——4,000 萬美元補助 UNC Lineberger，將直接實測腫瘤抗原與 T 細胞反應，讓個人化癌症疫苗不再是一場猜測遊戲。
-
Industry ENA Billion Dollars Against the Gradient: Gates Foundation Bets Big on Equitable AI
Alongside its 10th Goalkeepers Report, the Gates Foundation has committed at least $1 billion over two years — 40% education, 40% health, 10% agriculture, 10% language data — to push AI toward the world's poorest, with OpenAI, Anthropic, Google and Microsoft named as partners.
-
Industry 中十億美元對抗傾斜的天平：蓋茲基金會重押「公平 AI」
蓋茲基金會配合第十份年度 Goalkeepers 報告宣布：未來兩年投入至少 10 億美元發展公平 AI——教育與醫療各佔 40%、農業 10%、語言資料集 10%，OpenAI、Anthropic、Google 與微軟均列為合作夥伴。
-
Research EN400,000 Reddit Posts, One Algorithm: AI Surfaces GLP-1 Side Effects Clinical Trials Missed
Penn researchers used LLMs to mine 400,000 Reddit posts from nearly 70,000 GLP-1 users, surfacing menstrual changes, chills, hot flashes and fatigue that rarely appear on drug labels — a template for AI-driven pharmacovigilance.
-
Research 中40 萬則 Reddit 貼文、一個模型：AI 找出臨床試驗沒發現的 GLP-1 副作用
賓大研究團隊用大型語言模型分析近 7 萬名 GLP-1 用藥者的 40 萬則 Reddit 貼文，找出月經週期改變、畏寒、潮熱與疲勞等鮮少出現在藥品標示上的訊號——也為 AI 藥物安全監測立下新範本。
-
Research ENFrom Lab Bench to Battlefield Tourniquet: MIT's AI-GUIDE Wins Federal Tech-Transfer Award as Novice Study Hits 93%
MIT Lincoln Laboratory and Mass General's AI-guided vascular access device takes the Federal Laboratory Consortium's 2026 Excellence in Technology Transfer Award, with a new user-validation study showing 93% first-pass needle-insertion success for clinicians with minimal ultrasound training.
-
Research 中從實驗室到戰場止血帶：MIT 的 AI-GUIDE 獲聯邦技術轉移大獎，新手操作成功率达 93%
MIT 林肯實驗室與麻省總醫院合作的 AI 導引血管通路裝置，榮獲聯邦實驗室聯盟 2026 年技術轉移卓越獎；最新使用者驗證研究顯示，超音波經驗有限的醫護人員操作下，模擬穿刺成功率高達 93%。
-
Industry ENThe Iron Man Suit for Radiologists: Epsilon Health Exits Stealth With $27.6M and 1% of America's Daily X-Rays
The San Francisco startup is building an AI-native radiology practice — not another tool for doctors to learn — and is already on track to read 1% of all daily U.S. X-rays in its first year.
-
Industry 中放射科醫師的鋼鐵人裝甲：Epsilon Health 攜 2,760 萬美元走出隱身期，一年內讀取全美每日 X 光片的 1%
這家舊金山新創打造的不是另一套讓醫師學習的 AI 工具，而是一家「AI 原生放射科診所」——營運不到一年，已朝向解讀全美每日 X 光檢查的 1% 邁進。
-
Policy EN44 Recommendations, 12,000 Voices: The UK Just Published Its Blueprint for Regulating AI in Healthcare
The National Commission into the Regulation of AI in Healthcare proposes AI 'L-plates', lifelong monitoring, and patient transparency rights for the NHS — the most detailed framework of its kind.
-
Policy 中44 項建議、12,000 位民意：英國發布醫療 AI 監管藍圖
英國醫療 AI 監管國家委員會提出 AI「學習駕照」制度、終身監控與病人知情權，為 NHS 打造迄今最完整的 AI 醫療監管框架。
-
Research EN49 Billion Compounds, Nine Finalists, One Approval: Inside Mprosevir, China's First AI-Assisted Class 1 Drug
China's NMPA has granted conditional approval to Mprosevir, an AI-assisted COVID-19 antiviral that went from candidate discovery to completed clinical trials in 3.5 years — the world's first approved small molecule born from DNA-encoded library technology.
-
Research EN49 億化合物、9 個入圍者、1 張藥證：解析中國首款 AI 輔助一級新藥 Mprosevir
中國國家藥監局有條件核准 Mprosevir——一款 AI 輔助開發的 COVID-19 抗病毒藥物，從候選藥物發現到臨床試驗完成僅花 3.5 年，也是全球首款源自 DNA 編碼文庫技術獲批的小分子新藥。
-
Research ENNine Billion Variants, One Petabyte: DeepMind's AlphaGenome Atlas Precomputes Every Possible DNA Letter Change
Google DeepMind has released AlphaGenome Atlas, a 1-petabyte dataset predicting the molecular effects of all ~9 billion possible single-letter DNA variants in the human genome — 30x larger than the AlphaFold Database — free for academic use.
-
Research 中九十億個變異、一 PB 資料量：DeepMind AlphaGenome Atlas 預先算好人類基因體每個字母的改變
Google DeepMind 發布 AlphaGenome Atlas，一個 1 PB 的資料集，預測人類基因體中約 90 億個所有可能單字母 DNA 變異的分子效應 — 比 AlphaFold 資料庫大 30 倍以上，學術用途免費開放。
-
Industry ENToo Complex for Humans, Solvable for Machines: Arm's Rene Haas Says AI Will Cure Cancer
Arm's CEO tells the BBC that AI will find cancer cures humans cannot, humanoid robots arrive within five years, and the real bottleneck is chips — with Meta's $2bn Arm AGI demand 'off the charts'.
-
Industry 中人類解不開、機器能解開：Arm 執行長 Haas 宣稱 AI 將治癒癌症
Arm 執行長向 BBC 表示，AI 將找出人類無法發現的癌症療法、五年內人形機器人將普及，而真正的瓶頸是晶片——Meta 的 Arm AGI 晶片需求「爆表」，已超過 20 億美元。
-
Industry ENAI Will Cure Cancer, Says Arm's CEO — If the Chip Supply Holds
Arm CEO Rene Haas tells the BBC that AI will crack cancer's complexity in our lifetimes and put humanoid robots to work within five years — but warns chip shortages are the real bottleneck.
-
Industry 中Arm 執行長：AI 將治癒癌症——前提是晶片供應跟得上
Arm 執行長 Rene Haas 接受 BBC 專訪時表示，AI 有生之年將破解癌症的複雜性、五年內人形機器人將廣泛應用，但晶片短缺才是真正的瓶頸。
-
Research ENTell It You're Fine and It Agrees: Chatbots Drop Sleep Apnea Referrals in 1 in 3 Cases
A 700-conversation ERS Congress study finds free AI chatbots give perfect referral advice to cooperative patients — but abandon it 36% of the time when patients push back, and 78% of the time in severe cases.
-
Research 中你說沒事，它就同意：研究顯示聊天機器人在三分之一案例中放棄睡眠呼吸中止轉診建議
ERS 年會發表的 700 對話研究發現：免費 AI 聊天機器人面對配合的病人給出完美轉診建議，但病人一反對就棄守——整體棄守率 36%，嚴重案例更高達 78%。
-
Policy EN60,000 Opt-Outs in Two Months: UK Health Minister Warns Palantir 'Mistrust' Is Now a Research Problem
A government minister has put Palantir's NHS contract on notice: 60,000 patients withdrew their data in two months, trusts no longer must use the £330m federated data platform, and February's break clause is looming.
-
Policy 中兩個月六萬人退出資料共享：英國衛生大臣警告，對 Palantir 的「不信任」已成了研究危機
英國衛生創新部長 James Frith 首度承認，民眾對 Palantir 的不信任正侵蚀 NHS 研究基礎：兩個月內六萬人申請退出資料共享， 信託機構不再被強制使用 3.3 億英鎊的聯邦數據平台，二月的中止條款進入倒數計時。
-
Research ENThree to Six Years Younger, By Every Clock: Insilico's AI-Designed Drug Shows Biological Age Reversal in Phase IIa
Six independent proteomic aging clocks unanimously found that rentosertib — the first drug with both an AI-discovered target and an AI-generated molecule — reversed patients' predicted biological age by 3–4 years, up to 6, in a Phase IIa IPF trial.
-
Research 中六個老化時鐘全數同意：英矽智能 AI 設計藥物在二期試驗中逆轉生理年齡 3 至 6 年
六個獨立開發的蛋白質體老化時鐘一致發現，rentosertib——首款標靶與分子皆由 AI 發現及設計的藥物——在特發性肺纖維化二期試驗中，讓受試者的預測生理年齡平均年輕 3–4 年，最高達 6 年。
-
Industry EN85% of Scans Still Booked by Fax: Inside Scan.com's $220M Bid to Wire Up US Medical Imaging
Scan.com raised $220M ($90M Series C equity led by Noteus Partners plus $130M in debt) to build a national API that uses AI to match every imaging referral to the right scanner by availability, price, and subspecialty.
-
Industry 中85% 的檢查仍靠傳真預約：Scan.com 以 2.2 億美元打造美國醫學影像的國家級 API
Scan.com 完成 2.2 億美元融資（Noteus Partners 領投 9,000 萬美元 C 輪加上 1.3 億美元債務融資），要用 AI 依可用時段、價格與次專科，把每一張影像檢查轉診單媒合到對的掃描儀。
-
Industry ENThe Singularity's Chief Prophet Signs On: Ray Kurzweil Joins Nanoparticle BCI Startup Subsense
Ray Kurzweil, the futurist who popularized the 2045 singularity, has joined Palo Alto startup Subsense as product and vision advisor — betting on a brain-computer interface you administer through your nose.
-
Industry 中奇點先知親自下場：Ray Kurzweil 加入鼻腔奈米粒子 BCI 新創 Subsense
預言 2045 年奇點到來的未來學家 Ray Kurzweil，宣布加入 Palo Alto 新創 Subsense 擔任產品與願景顧問——押注一款用「鼻子吸入」的腦機介面。
-
Research ENThe CT Scan You Already Had: COCA Finds Colorectal Cancer Hiding in 27,000 Routine Scans
A deep learning model from Alibaba's DAMO Academy detects colorectal cancer on routine noncontrast CT with 86.6-88.2% real-world sensitivity and 99.5% specificity — and it caught 5 cancers clinicians missed.
-
Research 中你早就照過的 CT：COCA 從 2.7 萬張例行掃描中揪出大腸癌
阿里巴巴達摩院等機構研發的深度學習模型 COCA，能在例行無顯影劑 CT 上以 86.6%–88.2% 的實世界敏感度偵測大腸癌，特異度達 99.5% 以上，並抓出 5 例臨床漏診的癌症。
-
Meta ENOne Robot for Aging Alone: Tuya's Doova Wants to Be the Whole Answer
At IFA 2026 in Berlin, Tuya Smart unveiled Doova, an AI home companion robot for seniors living alone that combines fall detection, 60-second emergency escalation, conversational companionship, and smart-home control in one soft-bodied device.
-
Meta 中一臺機器人，照顧獨老生活：塗鴉智能 Doova 想一次給出全部答案
塗鴉智能（Tuya Smart）在柏林 IFA 2026 發表居家陪伴機器人 Doova，鎖定獨居長者：整合跌倒偵測、60 秒緊急通報、自然對話陪伴與智慧家庭中控於一身。
-
Research ENBiology's Fourth Act: Inside AI BioDesign, the $95 Million Bet to Engineer Life Beyond Evolution
The Allen Institute, UW Medicine, and Fred Hutch launch AI BioDesign with $95M from Paul Allen's FFST — a design-build-measure-learn loop pairing Nobel laureate David Baker's protein design with open AI models to explore biology's full design space, from cancer-killing cells to plastic-eating enzymes.
-
Research 中生物學的第四幕：AI BioDesign 以 9,500 萬美元押注超越演化的生命工程
Allen Institute、華盛頓大學醫學院與 Fred Hutch 癌症中心攜手推出 AI BioDesign，獲 Paul Allen 基金會 FFST 挪出 9,500 萬美元支持——以「設計—建構—測量—學習」閉環結合諾貝爾獎得主 David Baker 的蛋白質設計與開放 AI 模型，探索從清除癌細胞到分解海洋塑膠的完整生物設計空間。
-
Models ENFour Doctors of the AI Age: OpenEvidence Launches Osler, Sackett, Snow — and Keeps Darwin Locked Up
OpenEvidence ships a family of medical AI models named for medicine's greatest minds, claims the first perfect MedQA score with Darwin, and holds its most powerful model back over bioweapon-grade dual-use risk.
-
Models 中AI 時代的四位醫師：OpenEvidence 發布 Osler、Sackett、Snow 模型——卻把 Darwin 鎖在門後
OpenEvidence 推出以醫學史大師命名的醫療 AI 模型家族，Darwin 宣稱首度在 MedQA 拿下滿分，卻以生物武器等級的雙用風險為由，將最強模型限制為僅供申請研究使用。
-
Policy ENThirty AI Bills, One Signature Line: California's 2026 Session Ends With the Nation's Biggest Regulatory Pile on Newsom's Desk
California lawmakers wrapped their 2026 session near midnight Aug. 31 after final-approving roughly 30 AI bills — from Adam's Law chatbot safety to a rule declaring AI is not a legal 'person.' Gov. Newsom has until Sept. 30 to sign or veto the largest single-state AI regulatory package in U.S. history.
-
Policy 中30 個 AI 法案、一條簽名線：加州 2026 會期落幕，全美最大監管包裹等著紐森裁決
加州議員在 8 月 31 日接近午夜時結束 2026 會期，最終通過約 30 個 AI 相關法案——從 Adam's Law 聊天機器人安全到「AI 不是法律上的『人』」，州長紐森必須在 9 月 30 日前決定簽署或否決這批美國史上單一州最大規模的 AI 監管包裹。
-
Tools ENChatGPT Meets the Chart: OpenAI's Epic EHR Integration Puts AI Inside 325 Million Patient Records
OpenAI has wired ChatGPT Health directly into Epic's electronic health record system in a read-only integration spanning 325 million patients — the deepest push yet by a frontier AI lab into clinical workflow.
-
Tools 中ChatGPT 走進病歷：OpenAI 的 Epic 病歷系統整合，把 AI 帶進 3.25 億病人的資料庫
OpenAI 宣布 ChatGPT Health 以唯讀方式直接接入 Epic 電子病歷系統——這是前沿 AI 實驗室迄今對臨床工作流程最深的一次滲透。
-
Meta ENVara Wins World-First CE Mark for Autonomous AI in Breast Cancer Screening: The Machine Now Reads the Normals
Berlin-based Vara has received the world's first CE certification (EU MDR Class IIb) for autonomous AI triage in organized breast cancer screening — normal mammograms can now be reported with no radiologist reading them, guarded by a seven-year real-world monitoring system called ATMON.
-
Meta 中Vara 拿下全球首張乳癌篩查自主 AI 的 CE 認證：正常片子，機器可以直接出報告了
柏林新創 Vara 獲得全球第一張針對乳癌族群篩查自主分流的 CE 認證（EU MDR Class IIb）——被判定位明確正常的乳腺 X 光攝影，如今可以完全不由放射科醫師閱片、由 AI 直接出具報告，背後靠的是名為 ATMON、累積七年真實世界監控數據的安全系統。
-
Industry ENOwkin Licenses Its K Pro 'AI Scientist' and Multimodal Patient Data to Boehringer Ingelheim
The Paris-New York agentic AI company will license K Pro and its MOSAIC oncology atlas to Boehringer, and generate fresh multimodal immunology data — the third big-pharma K Pro deal of 2026.
-
Industry ENOwkin 將 K Pro「AI 科學家」與多模態病患數據授權給百靈佳殷格翰
這家巴黎-紐約雙總部的 Agentic AI 公司，將授權 K Pro 與 MOSAIC 癌症空間多體學圖譜給百靈佳殷格翰，並為其新生成免疫領域的多模態數據——這是 2026 年第三筆大型藥廠 K Pro 授權案。
-
Tools ENQualcomm and ASUS Put a 20B-Parameter Pharmacy AI Agent on the Counter: Offline, On-Device, and Built for Taiwan's Super-Aged Society
Qualcomm and ASUS launched the Pharmaceutical AI Agent: a GPT-OSS 20B model distilled from 120B to run locally on Snapdragon-powered AI PCs, reviewing 28 prescription safety metrics against TFDA drug data for 50+ community pharmacies in southern Taiwan — fully offline, no cloud required.
-
Tools 中Qualcomm 與華碩把 200 億參數的藥局 AI 代理搬上櫃檯：離線、在地運算，為台灣超高齡社會而生
Qualcomm 與華碩集團發表「藥事 AI 代理」（Pharmaceutical AI Agent）：將 GPT-OSS 從 1,200 億參數蒸餾到 200 億，可在 Snapdragon AI PC 上完全本地運算，對照 TFDA 藥品說明書資料庫自動檢核 28 項處方安全指標，部署於南台灣 50 多家社區藥局——全程離線、無需雲端。
-
Tools ENChatGPT Health Plugs Into Epic: OpenAI Lands Inside 325 Million Patient Records
OpenAI's ChatGPT Health now integrates with Epic's EHR, giving clinicians read-only AI access to appointment notes, labs, meds, and specialist docs across 325M+ patient records.
-
Tools 中ChatGPT Health 串接 Epic：OpenAI 正式走進 3.25 億筆病歷資料
OpenAI 宣布 ChatGPT Health 與 Epic 電子病歷系統整合，讓臨床醫師以唯讀方式匯入約診紀錄、檢驗報告、用藥與專科文件，覆蓋超過 3.25 億名病人的資料。
-
Research ENSt. Jude's AdaptiveFlow Screens 69 Billion Molecules for 1,000x Less: AI Drug Discovery Gets a Cloud-Native Rewrite
St. Jude's open-source AdaptiveFlow platform steers 69-billion-molecule virtual screens with active learning, scales to 5.6 million cloud CPUs, and cuts screening costs up to 1,000-fold while discovering validated nanomolar FSP1 and PARP-1 inhibitors.
-
Research 中St. Jude 的 AdaptiveFlow 以千分之一成本篩選 690 億分子：AI 藥物發現的雲端重寫
St. Jude 開源平台 AdaptiveFlow 以主動學習導引 690 億分子的虛擬篩選、可在 AWS 上擴展至 560 萬顆 CPU，並將篩選成本最高降低 1,000 倍，同時發現經實驗驗證的奈莫耳級 FSP1 與 PARP-1 抑制劑。
-
Research EN'Superhuman' AI Reads ECGs in Under 2 Seconds, Spotting Hidden Heart Disease
An Imperial College London AI trained on millions of ECGs detects heart failure and valve disease in under two seconds, identifying up to 81% and 90% of cases respectively in a 67,000-patient US trial.
-
Research 中「超人力」AI 兩秒內讀懂心電圖，揪出隱藏心臟病
帝國理工學院研發的 AI 以數百萬筆心電圖訓練，兩秒內偵測心臟衰竭與瓣膜疾病，在 6.7 萬人美國試驗中分別找出最高 81% 與 90% 的病例。
-
Policy ENNHS Watchdog Warns Doctors' AI Scribes Get Drug Names and Diagnoses Wrong
Healthwatch England says NHS patients are catching dangerous AI transcription errors — wrong drugs, wrong diagnoses — that doctors miss, as 27 scribe tools spread with no England-wide oversight.
-
Policy 中英國 NHS 監督機構警告：AI 門診抄寫員會寫錯藥名與診斷
Healthwatch England 指出，NHS 病患正親眼抓出醫生漏掉的危險 AI 轉錄錯誤——寫錯藥物、寫錯診斷；而 27 款抄寫工具快速普及，英格蘭卻缺乏全國性監管機制。
-
Policy ENCalifornia's Final-Passage Weekend: 24 AI Bills Race the Aug. 31 Adjournment Clock
Three AI bills are already on Gov. Newsom's desk and 21 more await final votes as California lawmakers work through the weekend ahead of Monday's adjournment — covering chatbots, healthcare AI, labor protections, and digital replicas.
-
Policy 中加州立法最後衝刺：24 項 AI 法案趕在 8 月 31 日休會前過關
三項 AI 法案已送交州長紐森簽署，另有 21 項等待最後表決——加州議員週末加班趕在週一休會前處理聊天機器人、醫療 AI、勞工保護與數位分身等法案。
-
Research ENAI Reads Routine Mammograms and Spots Heart Disease in Women, Major Study Finds
Israeli researchers used machine learning on 97,000+ mammograms to identify women with stroke, hypertension and coronary heart disease — turning breast screening into a dual-purpose cardiovascular tool.
-
Research 中AI 讀乳房 X 光就能揪出心臟病：大規模研究揭示乳癌篩檢的第二使命
以色列研究團隊用機器學習分析超過 9.7 萬張乳房 X 光片，成功辨識出曾中風、罹患高血壓與冠心病的女性，讓乳癌篩檢化身心血管疾病偵測工具。
-
Research ENOne in Three American Adults Now Uses AI Chatbots for Health — Pew
Pew's survey of 3,488 U.S. adults finds 34% now use AI chatbots for health tasks — from self-diagnosis to decoding lab results — and nearly all find them helpful, yet only 29% are comfortable sharing personal health data, and Americans say chatbots hurt more than help with loneliness and depression.
-
Research ENAI Reads Mammograms for Heart Disease: 97,000-Scan Study Hits 86% Stroke Detection
Presented at ESC Congress 2026 in Munich, an Israeli study of 97,364 mammograms shows a machine-learning model can flag stroke, hypertension, and coronary heart disease in women from breast scans alone — no extra imaging required.
-
Research 中AI 從乳房攝影讀出心臟病：97,000 張掃描研究達 86% 中風偵測率
於慕尼黑 ESC 2026 年會發表的以色列研究,分析 97,364 張乳房攝影,顯示機器學習模型能僅凭乳房掃描就標記出中風、高血壓與冠狀動脈心臟病——無需額外影像檢查。
-
Research ENAI Reads Mammograms and Finds Heart Disease: Tel Aviv Team's 97,000-Scan Breakthrough at ESC 2026
A machine-learning model trained on 97,364 mammograms from nearly 30,000 women identified stroke with 86% accuracy and hypertension with 79% — turning the world's most routine cancer screening into a dual-purpose cardiovascular test.
-
Research 中AI 讀乳房 X 光揪出心臟病：特拉維夫團隊在 ESC 2026 發表 9.7 萬張掃描的突破研究
機器學習模型分析近 3 萬名女性的 97,364 張乳房 X 光，以 86% 準確率找出中風、79% 找出高血壓——讓全球最普及的癌症篩檢搖身成為雙用途的心血管檢測。
-
Industry ENHuawei Widens Its AI Pharma Push: From Compound Screening to the Clinic
Huawei's healthcare president William Zhang says the company will expand AI cooperation with Chinese drugmakers into drug development and clinical practice — riding its Ascend and Kunpeng chips into a market where Nvidia has already partnered with Eli Lilly and Novo Nordisk.
-
Industry 中華為擴大 AI製藥布局：從分子篩選一路推進臨床
華為醫療事業總裁張強表示，將把與中國藥企的 AI 合作從早期研究擴展到藥物開發與臨床實踐——憑藉昇騰與鯤鵬晶片，切入輝達已與禮來、諾和諾德結盟的 AI 製藥市場。
-
Research ENWorld First: Live AI Guides Brain Surgery, Saves Patient's Sight
Surgeons at London's National Hospital for Neurology and Neurosurgery have performed the world's first live AI-assisted brain tumour removal, with the AI reading the surgical video feed in real time.
-
Research 中世界首例：AI 即時輔助腦部手術成功挽救患者視力
倫敦國家神經學與神經外科醫院完成全球首次由 AI 即時輔助的腦瘤切除手術，AI 直接分析手術影像串流，協助避開隱藏的血管與神經。
-
Research ENOne in Three American Adults Now Uses AI Chatbots for Health Information
A new Pew survey finds 34% of U.S. adults turn to AI chatbots for health reasons — from diagnosing symptoms to decoding lab results — and nearly all of them find the answers helpful.
-
Research 中每三個美國成人就有一個用 AI 聊天機器人查健康資訊
Pew 最新調查發現,34% 的美國成人會出於健康理由使用 AI 聊天機器人——從自我診斷到解讀檢驗報告——而且幾乎所有人都覺得答案有幫助。
-
Policy ENAnthropic Puts $5 Million Behind Independent Research on AI's Impact on User Wellbeing
Anthropic launched a $5 million grant program on August 25, 2026 to fund fully independent, open-source evaluations of how AI models affect user wellbeing — applications close September 21, with full-proposal invites going out October 5.
-
Policy 中Anthropic 投入 500 萬美元，資助獨立研究 AI 對使用者福祉的影響
Anthropic 於 2026 年 8 月 25 日宣布啟動 500 萬美元補助計畫，資助完全獨立、開源的研究，評測 AI 模型對使用者福祉的影響——申請截止於 9 月 21 日，10 月 5 日通知入選者提交完整提案。
-
Industry ENIndia's Airbound Raises $37M to Make Drone Delivery Cheaper Than Trucks
Bengaluru-based Airbound raised a $37M Series A led by Greenoaks to build tail-sitter drones that weigh less than their cargo — and a 10,000-flights-a-day network in Andhra Pradesh.
-
Industry 中印度新創 Airbound 募得 3,700 萬美元，要讓無人機送貨比卡車更便宜
班加羅爾新創 Airbound 完成 3,700 萬美元 A 輪募資（Greenoaks 領投），打造機身比貨物更輕的尾座式無人機，並與安得拉邦合作目標每日 1 萬航班。
-
Tools ENFDA Clears Tempus AI's ECG-PH: Spotting Pulmonary Hypertension From a Standard ECG
Tempus AI's third FDA-cleared cardiac algorithm reads routine 12-lead ECGs for hidden signs of pulmonary hypertension, a disease that hits up to 10% of adults over 65.
-
Tools 中FDA 核准 Tempus AI 的 ECG-PH：從標準心電圖揪出肺動脈高壓
Tempus AI 第三個取得 FDA 許可的心血管 AI 演算法，能從例行 12 導極心電圖讀出肺動脈高壓的隱藏訊號——這種疾病影響多達 10% 的 65 歲以上成人。
-
Research ENFirst Phase 3 Win for a Personalized mRNA Cancer Vaccine — Built on a Neoantigen-Picking Algorithm
Merck and Moderna's intismeran autogene plus Keytruda met both endpoints in the 1,137-patient INTerpath-001 melanoma trial — the first Phase 3 validation of an AI-screened, per-patient mRNA vaccine.
-
Research 中個人化 mRNA 癌症疫苗首度通過第三期試驗——背後是一套挑選新生抗原的演算法
默沙東與莫德納的 intismeran autogene 合併 Keytruda，在 1,137 人的 INTerpath-001 黑色素瘤試驗中同時達成主要與次要終點——這是 AI 篩選、每人專屬的 mRNA 疫苗首度獲得三期臨床驗證。
-
Models ENGemma Passes 1 Billion Downloads: Google's Open Weights Now Run From Orbit to the Ocean Floor
Google DeepMind says its Gemma open models passed 1 billion cumulative downloads, with 100,000+ community variants running everywhere from satellites in orbit to India's national health app.
-
Models 中Gemma 下載量突破 10 億次:Google 的開放權重模型已從軌道部署到深海
Google DeepMind 宣布 Gemma 開放模型累積下載量突破 10 億次,社群變體超過 10 萬個,部署範圍從軌道上的衛星到印度的全國健康應用。
-
Policy EN24 AI Bills, One Week: California's Regulatory Sprint Hits the Final Stretch
California lawmakers have until August 31 to pass two dozen AI bills covering chatbot safety, healthcare AI, worker protections, and digital replicas — the closing act of a year that has already produced 85 new state AI laws.
-
Policy 中24 條 AI 法案、最後一週：加州監管衝刺進入終局
加州議員必須在 8 月 31 日休會前，表決通過涵蓋聊天機器人安全、醫療 AI、勞工保護與數位分身的 24 條 AI 法案——而這只是今年全美 27 州已通過 85 條新 AI 法律的最新一章。
-
Research ENClaude Designed Working Protein Binders for 14 of 15 Targets — No Human in the Loop
Anthropic ran Claude autonomously through full protein binder design campaigns: 354 of 1,320 designs bound in wet-lab tests, beating open competition entries on hit rate and affinity.
-
Research 中Claude 自主設計蛋白質結合器，15 個目標中 14 個成功——全程無人干預
Anthropic 讓 Claude 全自主執行完整蛋白質結合器設計流程：1,320 個設計中有 354 個通過濕實驗室驗證，命中率和親和力均超越公開競賽作品。
-
Research ENDeep Origin's DODock Cracks Virtual Screening: 30% Hit Rate on CD73, 100x the AI Benchmark
A physics-plus-ML docking engine held 80% pose accuracy on novel targets where AlphaFold 3-class models fall below 25% — and turned a 0.3% CD73 screen into 30.6%.
-
Research 中Deep Origin 的 DODock 突破虛擬篩選瓶頸：CD73 命中率達 30%，較 AI 基準提升百倍
結合物理與機器學習的對接引擎在全新靶點上維持 80% 位姿準確率——AlphaFold 3 等級的共同摺疊模型在同類測試中跌破 25%，並將 CD73 篩選命中率從 0.3% 推升至 30.6%。
-
Research EN1,357 AI Medical Devices Cleared by the FDA — Only 3 Tested on Patient Outcomes
A PLOS Digital Health review finds that of 1,357 FDA-authorized AI medical devices, just 3 were evaluated on outcomes patients actually care about — survival, hospitalization, quality of life.
-
Research 中FDA 核可的 1,357 個 AI 醫療器材，只有 3 個驗證過對病人預後的影響
PLOS Digital Health 的一項大型回顧研究發現，在 FDA 核可的 1,357 個 AI 醫療器材中，僅 3 個曾以存活率、住院率、生活品質等病人真正在乎的指標進行評估。
-
Research ENClaude Designs Working Protein Binders Against 14 of 15 Targets: Anthropic's Lab-Validated Biology Results
Anthropic reports Claude autonomously designed de novo protein binders that succeeded against 14 of 15 wet-lab targets with 22–35% hit rates — more than double the field's 10–15% norm — plus NMR/LC-MS analysis in minutes instead of days.
-
Research 中Claude 設計出 15 個標的中 14 個可用的蛋白質結合子：Anthropic 的實驗室驗證生物學成果
Anthropic 發布濕實驗室驗證結果：Claude 在 Claude Science 環境中自主設計全新蛋白質結合子，15 個標的中成功命中 14 個，命中率 22–35%——是業界常態 10–15% 的兩倍以上，並將 NMR/LC-MS 分析從數天縮短到 23 分鐘。
-
Industry ENEliseAI in Talks to Raise $300M at a $3.7B Valuation as Vertical AI Agents Go Mainstream
EliseAI, the New York startup whose AI agents run admin work for America's largest landlords and healthcare providers, is reportedly in talks to raise ~$300M at a $3.7B valuation — a 68% jump from its last round, backed by five straight years of 100% revenue growth.
-
Industry 中EliseAI 傳洽談以 37 億美元估值募資 3 億美元,垂直 AI 代理邁向主流
為美國最大房東與醫療機構處理行政工作的紐約新創 EliseAI,傳正洽談以 37 億美元估值募資約 3 億美元,較一年前估值大增 68%,背後是連續五年營收翻倍的成長曲線。
-
Research ENClaude Designs Protein Binders Better Than Human Experts: Anthropic's 14-of-15 Campaign and a 23-Minute Chemistry Workflow
Anthropic reports that Claude designed protein binders against 14 of 15 targets with hit rates up to 35% — roughly triple the human-typical 10-15% — and processed raw NMR and LC-MS instrument files in minutes, matching a contract lab's own analysis.
-
Policy ENMeta on Trial: States Open Landmark Youth Addiction Case With $200 Billion on the Line
Opening arguments began August 18 in Oakland in the biggest legal test yet of whether social media platforms are addictive by design, with California, Colorado, Kentucky and New Jersey seeking roughly $200 billion from Meta.
-
Policy 中Meta 站上法庭：29 州青少年成癮世紀訴訟開審，索賠金額逼近 2,000 億美元
2026 年 8 月 18 日，加州奧克蘭聯邦法院正式開審 Meta 青少年成癮案——這是社群媒體產業迄今最大規模的法律對決，加州等四州求償近 2,000 億美元。
-
Tools ENThe ChatGPT Dog Cancer Vaccine Is Now a Real YC Startup
Gamgee, the Y Combinator S26 startup turning Paul Conyngham's viral ChatGPT-designed mRNA cancer vaccine for his dog Rosie into a clinical platform, is now recruiting trial patients worldwide.
-
Tools 中ChatGPT 設計的狗癌症疫苗,如今成為真正的 YC 新創公司
Gamgee 這家 Y Combinator S26 新創,把創辦人 Paul Conyngham 用 ChatGPT 為愛犬 Rosie 設計 mRNA 癌症疫苗的爆紅故事,變成臨床平台,現正全球招募試驗病例。
-
Tools ENAbbott and Google Team Up: AI Health Coaching Meets Continuous Glucose Monitoring
Abbott's Lingo CGM is connecting to Google Health's AI coach in a multi-year partnership aiming to make metabolic health actionable for millions.
-
Tools 中Abbott 攜手 Google：AI 健康教練遇上連續血糖監測
Abbott 的 Lingo 連續血糖監測器將接入 Google Health 的 AI 教練，這項多年期合作要讓代謝健康洞察變得人人可用。
-
Research ENSamsung's On-Device Health AI: xMAE and HiMAE Bring Clinical-Grade Biosignal Analysis to the Wrist
Samsung Research America unveiled two health foundation models — xMAE and HiMAE — that analyze ECG, PPG, and sleep biosignals directly on smartwatch hardware with sub-millisecond inference, no cloud required.
-
Research 中三星裝置端健康 AI：xMAE 與 HiMAE 將臨床等級生理訊號分析帶上手腕
三星美國研究院發表兩款健康基礎模型 xMAE 與 HiMAE，可直接在智慧手錶等級硬體上分析 ECG、PPG 與睡眠生理訊號，推論速度低於一毫秒，完全無需雲端運算。
-
Industry ENAbbott and Google Health Partner to Bring AI-Powered Glucose Coaching to the Masses
Abbott's Lingo continuous glucose monitor is merging with Google Health's AI to deliver personalized metabolic coaching and one of the largest real-world metabolic health studies ever conducted.
-
Industry 中Abbott 攜手 Google Health：AI 血糖教練走向大眾健康的里程碑合作
Abbott 的 Lingo 連續血糖監測器與 Google Health 的 AI 結合，提供個人化代謝健康指導，並推動史上最大規模的真實世界代謝健康研究之一。
-
Policy ENOpenAI Foundation Commits $100M to AI-Powered Hepatitis C Elimination
The OpenAI Foundation partners with the Common Health Coalition on Breakthroughs to Follow-Through, a $100M initiative using AI to double hepatitis C cure rates across eight U.S. states.
-
Policy 中OpenAI 基金會承諾 1 億美元推動 AI 消除 C 型肝炎
OpenAI 基金會與 Common Health Coalition 攜手推出「突破到落實」計畫，投入 1 億美元運用 AI 在美國八個州將 C 型肝炎治癒率提高至少一倍。
-
Policy ENAnthropic Retunes Fable 5 Biology Safeguards, Cutting False Blocks by 85%
Anthropic rewrote the biology safety classifier for Claude Fable 5, reducing false-positive fallbacks by ~85% while keeping dual-use research locked down.
-
Policy 中Anthropic 重寫 Fable 5 生物安全分類器，誤攔率降低 85%
Anthropic 重新改寫 Claude Fable 5 的生物安全分類器，將誤判降級率降低約 85%，同時維持對病毒學、毒理學等雙重用途研究的嚴格封鎖。
-
Research ENGoogle's AMIE AI Matches Board-Certified Doctors in Real-Time Video Consultations
Google Research demonstrates AMIE — an AI system that conducts expert-level real-time video medical consultations, matching or beating primary care physicians on diagnostic accuracy, empathy, and clinical reasoning.
-
Research 中Google AMIE AI 在即時視訊看診中達到執照醫師水準
Google Research 展示 AMIE——一套能進行專家級即時視訊醫療看診的 AI 系統，在診斷準確率、同理心與臨床推理上匹敵甚至超越基層主治醫師。
-
Research ENStanford's Evo 2 Writes Viral Genomes No Evolution Ever Produced — and They Work
Stanford and Arc Institute researchers used the Evo 2 genome language model to design 16 fully functional bacteriophages from scratch — the first AI-generated viruses capable of killing antibiotic-resistant E. coli.
-
Research 中史丹佛 Evo 2 寫下演化未曾創造的病毒基因體——而且它們能正常運作
史丹佛大學與 Arc Institute 研究團隊運用 Evo 2 基因體語言模型，從零設計出 16 種完全具功能的全新噬菌體——這是首批能殺死抗藥性大腸桿菌的 AI 生成病毒。
-
Industry ENNovo Nordisk Bets Big on AWS: Inside the AI Co-Innovation Hub Reshaping Drug Discovery
Novo Nordisk named AWS its preferred cloud and AI partner, launching a co-innovation hub in London to compress drug discovery timelines using Amazon Bio Discovery and Bedrock AgentCore.
-
Industry 中諾和諾德攜手 AWS：倫敦 AI 共創樞紐如何重塑藥物研發
諾和諾德宣佈 AWS 為首選雲端與 AI 戰略夥伴，在倫敦設立共創樞紐，運用 Amazon Bio Discovery 與 Bedrock AgentCore 壓縮藥物研發時程。
-
Research ENStanford Researchers Create First AI-Designed Viruses Using Evo 2 Genome Models
A Stanford–Arc Institute team used generative AI models Evo 1 and Evo 2 to design 16 fully functional synthetic bacteriophages — the first time AI has written viable viral genomes from scratch.
-
Research 中史丹佛研究團隊以 Evo 2 基因體模型創造首批 AI 設計的病毒
史丹佛大學與 Arc Institute 團隊利用 Evo 1 與 Evo 2 生成式 AI 模型，設計出 16 株具完整功能的合成噬菌體——這是 AI 首次從零寫出可存活、可複製的病毒基因體。